Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.4, Iss.4, 2005-01, pp. : 245-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology of Potent New Bisphosphonates for Postmenopausal Osteoporosis

By Chapurlat Roland D.

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Combining Bisphosphonates with Hormone Therapy for Postmenopausal Osteoporosis

By Fadanelli Margaret E.

Treatments in Endocrinology, Vol. 3, Iss. 6, 2004-01 ,pp. : 361-369

Adis International

Access to resources Recommend Favorite

Raloxifene administration in post‐menopausal women with osteoporosis: effect of different Bsm I vitamin D receptor genotypes

By Palomba Stefano

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 192-198

Oxford University Press

Access to resources Recommend Favorite

Optimizing the Benefits of Bisphosphonates in Osteoporosis: The Importance of Appropriate Calcium Intake

By Boonen Steven Bouillon Roger Haentjens Patrick Vanderschueren Dirk

Treatments in Endocrinology, Vol. 5, Iss. 6, 2006-01 ,pp. : 375-383

Adis International

Access to resources Recommend Favorite

Plasma Leptin Concentrations in Postmenopausal Women with Osteoporosis

By Yilmazi Murat Keles Isik Aydin Gülümser Orkun Sevim Bayram Merih Ceylan Sevinc F. Kisa Üçler Yetkin Ilhan

Endocrine Research, Vol. 31, Iss. 2, 2005-04 ,pp. : 133-138

Informa Healthcare

Access to resources Recommend Favorite